Literature DB >> 16477433

99mTc-HYNIC-annexin V SPECT imaging of acute stroke and its response to neuroprotective therapy with anti-Fas ligand antibody.

Francis G Blankenberg1, Judy Kalinyak, Liping Liu, Maya Koike, Danye Cheng, Michael L Goris, Allan Green, Jean-Luc Vanderheyden, David C Tong, Midori Anne Yenari.   

Abstract

PURPOSE: The first aim of the study was to determine whether (99m)Tc-HYNIC-annexin V, a marker of cellular stress and apoptosis, can detect ischemic injury in patients with acute stroke. Secondly, we wished to test radiolabeled annexin's ability to monitor therapy in a rodent model of focal ischemic injury.
METHODS: SPECT imaging of patients was performed between 1 and 2 h after intravenous injection of 30 mCi (1,110 MBq) of tracer. Eight MFL4 (anti-FasL) antibody-treated (400 microg i.p. days 0 and 3) and 21 control adult male Sprague-Dawley rats underwent small animal SPECT imaging with 5-10 mCi (185-370 MBq) of tracer, 1 and 6 days after a 2-h intraluminal thread occlusion of the left middle cerebral artery.
RESULTS: Two patients with acute stroke had regions of multifocal annexin uptake that correlated with sites of restricted diffusion on MRI. Anti-FasL antibody treatment significantly reduced annexin uptake by 92% with a 60% decrease in the number of caspase-8 staining (apoptotic) neurons on day 1. On day 6, treated animals had an 80% reduction in tracer uptake with a 75% decrease in infarct size as compared with controls. Annexin uptake in controls and treated animals (day 6) linearly correlated with infarct size (r (2)=0.603, p=0.0036) and the number of TUNEL-positive (apoptotic) nuclei (r (2)=0.728, p=0.00084).
CONCLUSION: Annexin imaging shows foci of increased uptake at sites of ischemic injury in patients with acute stroke. Annexin imaging can assess the effects of therapy for ischemic cerebral injury in rats, suggesting its potential as a non-invasive indicator of drug efficacy in future clinical trials.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16477433     DOI: 10.1007/s00259-005-0046-6

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  46 in total

1.  Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death.

Authors:  A K Hammill; J W Uhr; R H Scheuermann
Journal:  Exp Cell Res       Date:  1999-08-25       Impact factor: 3.905

2.  Receiver operating characteristic evaluation of iterative reconstruction with attenuation correction in 99mTc-sestamibi myocardial SPECT images.

Authors:  K J LaCroix; B M Tsui; E C Frey; R J Jaszczak
Journal:  J Nucl Med       Date:  2000-03       Impact factor: 10.057

3.  Early and delayed induction of immediate early gene expression in a novel focal cerebral ischemia model in the rat.

Authors:  I M Johansson; P Wester; M Háková; W Gu; J R Seckl; T Olsson
Journal:  Eur J Neurosci       Date:  2000-10       Impact factor: 3.386

4.  Middle cerebral artery occlusion produces secondary, remote impairment in hippocampal plasticity of rats - involvement of N-methyl-D-aspartate receptors?

Authors:  M Sopala; T Frankiewicz; C Parsons; W Danysz
Journal:  Neurosci Lett       Date:  2000-03-10       Impact factor: 3.046

5.  Long-term changes of ionotropic glutamate and GABA receptors after unilateral permanent focal cerebral ischemia in the mouse brain.

Authors:  M Qü; T Mittmann; H J Luhmann; A Schleicher; K Zilles
Journal:  Neuroscience       Date:  1998-07       Impact factor: 3.590

6.  Annexin-V imaging for noninvasive detection of cardiac allograft rejection.

Authors:  J Narula; E R Acio; N Narula; L E Samuels; B Fyfe; D Wood; J M Fitzpatrick; P N Raghunath; J E Tomaszewski; C Kelly; N Steinmetz; A Green; J F Tait; J Leppo; F G Blankenberg; D Jain; H W Strauss
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

7.  Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage.

Authors:  H Hara; R M Friedlander; V Gagliardini; C Ayata; K Fink; Z Huang; M Shimizu-Sasamata; J Yuan; M A Moskowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

8.  Performance of ordered-subset reconstruction algorithms under conditions of extreme attenuation and truncation in myocardial SPECT.

Authors:  D S Lalush; B M Tsui
Journal:  J Nucl Med       Date:  2000-04       Impact factor: 10.057

9.  Cell surface-expressed phosphatidylserine and annexin A5 open a novel portal of cell entry.

Authors:  Heidi Kenis; Hugo van Genderen; Abdel Bennaghmouch; Hilde A Rinia; Peter Frederik; Jagat Narula; Leo Hofstra; Chris P M Reutelingsperger
Journal:  J Biol Chem       Date:  2004-09-20       Impact factor: 5.157

10.  Behavioral deficits and recovery following transient focal cerebral ischemia in rats: glutamatergic and GABAergic receptor densities.

Authors:  Jukka Jolkkonen; Nicola Palamero Gallagher; Karl Zilles; Juhani Sivenius
Journal:  Behav Brain Res       Date:  2003-01-22       Impact factor: 3.332

View more
  22 in total

Review 1.  Visualizing cell death in experimental focal cerebral ischemia: promises, problems, and perspectives.

Authors:  Marietta Zille; Tracy D Farr; Ingo Przesdzing; Jochen Müller; Clemens Sommer; Ulrich Dirnagl; Andreas Wunder
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-16       Impact factor: 6.200

2.  A dual-labeled Annexin A5 is not suited for SPECT imaging of brain cell death in experimental murine stroke.

Authors:  Marietta Zille; Denise Harhausen; Marijke De Saint-Hubert; Roger Michel; Chris P Reutelingsperger; Ulrich Dirnagl; Andreas Wunder
Journal:  J Cereb Blood Flow Metab       Date:  2014-07-02       Impact factor: 6.200

3.  Measuring response to therapy by near-infrared imaging of tumors using a phosphatidylserine-targeting antibody fragment.

Authors:  Jian Gong; Richard Archer; Michael Brown; Seth Fisher; Connie Chang; Matthew Peacock; Christopher Hughes; Bruce Freimark
Journal:  Mol Imaging       Date:  2013-06       Impact factor: 4.488

4.  70-kDa Heat Shock Protein Downregulates Dynamin in Experimental Stroke: A New Therapeutic Target?

Authors:  Jong Youl Kim; Nuri Kim; Zhen Zheng; Jong Eun Lee; Midori A Yenari
Journal:  Stroke       Date:  2016-07-07       Impact factor: 7.914

5.  Single-Photon Emission Computed Tomography/Computed Tomography Imaging in a Rabbit Model of Emphysema Reveals Ongoing Apoptosis In Vivo.

Authors:  Monica P Goldklang; Yared Tekabe; Tina Zelonina; Jordis Trischler; Rui Xiao; Kyle Stearns; Alexander Romanov; Valeria Muzio; Takayuki Shiomi; Lynne L Johnson; Jeanine M D'Armiento
Journal:  Am J Respir Cell Mol Biol       Date:  2016-12       Impact factor: 6.914

6.  Imaging caspase-3 activation as a marker of apoptosis-targeted treatment response in cancer.

Authors:  Delphine L Chen; Jacquelyn T Engle; Elizabeth A Griffin; J Philip Miller; Wenhua Chu; Dong Zhou; Robert H Mach
Journal:  Mol Imaging Biol       Date:  2015-06       Impact factor: 3.488

Review 7.  Phosphatidylserine targeting for diagnosis and treatment of human diseases.

Authors:  Kristof Schutters; Chris Reutelingsperger
Journal:  Apoptosis       Date:  2010-09       Impact factor: 4.677

Review 8.  Molecular imaging: 18F-FDG PET and a whole lot more.

Authors:  Todd E Peterson; H Charles Manning
Journal:  J Nucl Med Technol       Date:  2009-08-19

9.  FasL shedding is reduced by hypothermia in experimental stroke.

Authors:  Liping Liu; Jong Youl Kim; Maya A Koike; Yone Jung Yoon; Xian Nan Tang; Hualong Ma; Hokyou Lee; Gary K Steinberg; Jong Eun Lee; Midori A Yenari
Journal:  J Neurochem       Date:  2008-04-12       Impact factor: 5.372

10.  Transmembrane voltage regulates binding of annexin V and lactadherin to cells with exposed phosphatidylserine.

Authors:  Christina Smith; Donald F Gibson; Jonathan F Tait
Journal:  BMC Biochem       Date:  2009-02-17       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.